Correlation between Red Cell Distribution Width (RDW) and Mean Corpuscular Volume (MCV) as a Prognostic Biomarker for Diabetic Nephropathy Patients in a South Indian Hospital

A. Anandhasayanam *

SSM College of Pharmacy, Jambai, Erode, Affiliated to The TN Dr. MGR Medical University, Chennai, India.

S. Kannan

SSM College of Pharmacy, Jambai, Erode, Affiliated to The TN Dr. MGR Medical University, Chennai, India.

H. Hemanandhini

SSM College of Pharmacy, Jambai, Erode, Affiliated to The TN Dr. MGR Medical University, Chennai, India.

R. Rajamurugan

SSM College of Pharmacy, Jambai, Erode, Affiliated to The TN Dr. MGR Medical University, Chennai, India.

R. Ranjith

SSM College of Pharmacy, Jambai, Erode, Affiliated to The TN Dr. MGR Medical University, Chennai, India.

S. Rajamani

SSM College of Pharmacy, Jambai, Erode, Affiliated to The TN Dr. MGR Medical University, Chennai, India.

*Author to whom correspondence should be addressed.


Abstract

Context: Diabetic nephropathy is one of the microvascular complications of diabetes mellitus, capable of leading to end-stage renal disease. Diabetic nephropathy could only be identified through renal biopsy testing, which is expensive and can impose a financial burden on patients. Therefore, there is a necessity to develop a cost-effective method for identifying diabetic nephropathy.

Aim: To evaluate the correlation between RBC parameters, such as RDW and MCV values, as prognostic biomarkers for patients with diabetic nephropathy.

Methods and Material:

Study Design: Prospective comparative study.

Study Site: Sudha Institute of Medical Science, Erode.

Study Duration: Study was carried out over six-months.

Sample Size: 101 diabetic nephropathy patients and 101 type 2 diabetes mellitus patients.

Statistical Analysis: Pearson correlation.

Results: The majority of diabetic nephropathy patients were 40 years old or older, and most of them were males. Among the study participants, a significant number of male participants had habits of smoking and alcohol consumption. The duration of diabetes and BMI exhibited a strong correlation with the occurrence of diabetic nephropathy. Furthermore, there were notable increases in urea, creatinine, FBS, RBS, PPBS, and HbA1C, alongside a decrease in MCV and eGFR as diabetic nephropathy progressed.

Conclusions: Our research indicates a positive correlation between RDW and HbA1c, FBS, RBS, PPBS, urea, and creatinine. In contrast, negative correlation of RDW with MCV and eGFR. MCV is negatively correlated with HbA1c, FBS, RBS, PPBS, urea, creatinine. In contrast, positive correlation between MCV and eGFR.

Keywords: Diabetes mellitus, diabetic nephropathy, RDW, MCV


How to Cite

Anandhasayanam , A., Kannan , S., Hemanandhini , H., Rajamurugan , R., Ranjith , R. and Rajamani , S. (2024) “Correlation between Red Cell Distribution Width (RDW) and Mean Corpuscular Volume (MCV) as a Prognostic Biomarker for Diabetic Nephropathy Patients in a South Indian Hospital”, Journal of Pharmaceutical Research International, 36(4), pp. 1–10. doi: 10.9734/jpri/2024/v36i47507.

Downloads

Download data is not yet available.

References

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047–53

Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye and Vision. 2015;2(17): 1-25.

Gariani K, de Seigneux S, Pechère-Bertschi A, et al. Diabetic nephropathy: an update. Rev Med Suisse. 2012;8(330): 473–479.

Unnikrishnan R, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population. Diabetes Care. 2007;30(8) :2019–24.

Anders H-J, Huber TB, Isermann B, Schiffer M. CKD in diabetes: Diabetic kidney disease versus nondiabetic kidney Disease. Nature Reviews Nephrology. 2018;14(6):361–77.

Fiorentino M, Bolignano D, Tesar V, et al. Renal biopsy in patients with diabetes: a pooled metaa nalysis of 48 studies. Nephrol Dial Transpl. 2017;32(1):97–110.

Symeonidis A, Athanassiou G, Psiroyannis A, Kyriazopoulou V, Kapatais-Zoumbos K, Missirlis Y, et al. Impairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patients. Clin Lab Haematol. 2001;23(2): 103-9.

Bessman JD, Gilmer PR, Jr, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol. 1983;80(3): 322–326.

Nombwende G. Mean corpuscular volume (MCV): A suitable marker for the diagnosis of diabetic nephropathy in type 2 diabetes mellitus patients. Texila international journal of clinical research. 2019;6(1):32–44.

Arkew M, Yemane T, Mengistu Y, Gemechu K, Tesfaye G, Johnson C. Hematological parameters of type 2 diabetic adult patients at Debre Berhan Referral Hospital, Northeast Ethiopia: a comparative cross-sectional study. PLoS One. 2021;16(6):1–15

Yin Y, Ye S, Wang H, Li B, Wang A, Yan W, et al. Red blood cell distribution width and the risk of being in poor glycemic control among patients with established type 2 diabetes. Therapeutics and Clinical Risk Management. 2018;14:265–73.

Weiss, G. & Goodnough, L. T. Anemia of chronic disease. N Engl J Med.2005; 352(10):1011–1123.

Wakabayashi I. Relationships of habitual alcohol intake with erythrocyte-related indices in middle-aged Japanese men. Acta Haematologica. 2019;142(3):154–61.

Eid HA, Moazen EM, Elhussini M, Shoman H, Hassan A, Elsheikh A, et al. The influence of smoking on renal functions among apparently healthy smokers. Journal of Multidisciplinary Healthcare. 2022; 15:2969–78.

Orth SR. Smoking – a renal risk factor. Nephron. 2000;86(1):12–26.

Wu D, Zhai Q, Shi X. Alcohol-induced oxidative stress and cell responses. J Gastroenterol Hepatol. 2006;21(Suppl 3) :S26-S29.

Aml Mohamed Nada. Red cell distribution width in type 2 diabetic patients, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2015;8(1):525-533.

Singh Ray A, Kumar Kare P, Makwane DrH, Saxena DrT, Garg MrC. Estimation of serum creatinine, serum urea, glomerular filtration rate and proteinuria among apparently healthy adults to assess the renal impairment and its association with body mass index: An observational hospital-based study. International Journal of Medical Research and Review. 2020; 8(2):183–8.

Okabayashi Y, Tsuboi N, Sasaki T, Haruhara K, Kanzaki G, Koike K, et al. Single-nephron GFR in patients with obesity-related glomerulopathy. Kidney International Reports. 2020;5(8):1218– 27.

Mohan V, Vijayaprabha R, Rema M, Premalatha G, Poongothai S, Deepa R, Bhatia E, Mackay IR, Zimmet P. Clinical profile of lean NIDDM in South India. Diabetes Res Clin Pract. 1997;38:101–108.

Roy M, Banerjee A, Satyanarayanana P et al. Study of BMI, glucose level and lipid profile in type 2 diabetes mellitus. International Journal of Pharmaceutical Research. 2020;13(01):28-35.

Saltiel AR, Kahn CR. Insulin signaling and the regulation of glucose and lipid metabolism. Nature. 2001;414(6865):799–806.

Al-Rubeaan K, Youssef AM, Subhani SN, Ahmad NA, Al-Sharqawi AH, Al-Mutlaq HM, et al. Diabetic nephropathy and its risk factors in a society with a type 2 diabetes epidemic: A saudi national diabetes registry-based study. PLoS ONE. 2014;9 (2):1-9.

Giri B, Dey S, Das T, Sarkar M, Banerjee J, Dash SK. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: An update on glucose toxicity. Biomedicine & Pharmacotherapy. 2018; 107:306–28.

Bilir B, Ekiz Bilir B, Soysal Atile N, Takır M, Yılmaz A, Aydın M. Evaluation of red cell distribution width (RDW) in diabetic nephropathy patients. Medeniyet Medical Journal. 2016;31(3):156-160.

Kiykim A, Turgutalp K, Bardak S, Özcan T, Derici D. Red blood cell distribution width level: A predictive marker for early detection and monitoring of diabetic nephropathy progression. European Journal of Inflammation. 2014;12(1):109–16.

Alamri BN, Bahabri A, Aldereihim AA , Alabduljabbar M, Alsubaie MM, Alnaqeb D, Almogbel E, Metias NS, Alotaibi OA, Al-Rubeaan K. Hyperglycemia effect on red blood cells indices. Eur Rev Med Pharmacol Sci. 2019 ;23(5):2139-2150.

Mittal A, Sathian B, Kumar A, Chandrasekharan N, Sunka A. Diabetes mellitus as a potential risk factor for renal disease among napalese: A hospital-based case control study. NJE. 2010;1(1):22-25.

Renuka P, Bag S. Hemorheological Indices and Glycated Hemoglobin in Type 2 Diabetes Mellitus. Biomed Pharmacol J. 2020;13(4):1899-1902.